DNM1L and acute myeloid leukemia: Furthermore, Borthakur and colleagues reported that indirect inactivation of DRP1 through ERK1/2 inhibitors impairs mitochondrial fragmentation, leading to a significant loss of mitochondrial membrane potential and hypersensitivity to Venetoclax in a relapsed AML PDX [178].